Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Charlotte Finkenzeller"'
Autor:
Bernadette A.S. Jäger, Charlotte Finkenzeller, Carolin Bock, Leonie Majunke, Julia K. Jueckstock, Ulrich Andergassen, Julia K. Neugebauer, Aurelia Pestka, Thomas W.P. Friedl, Udo Jeschke, Wolfgang Janni, Sophie F. Doisneau-Sixou, Brigitte K. Rack
Publikováno v:
Translational Oncology, Vol 8, Iss 6, Pp 509-516 (2015)
BACKGROUND: We evaluated both estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2) status on disseminated tumor cells (DTCs) in the bone marrow of 54 patients with early breast cancer and compared these with the corresponding pr
Externí odkaz:
https://doaj.org/article/b76ad74c8490456398f6deb59267e44b
Autor:
Thomas W. P. Friedl, Bernadette Jäger, Sophie F. Doisneau-Sixou, Wolfgang Janni, Julia Neugebauer, Julia Kathrin Jueckstock, Aurelia Pestka, Charlotte Finkenzeller, Leonie Majunke, Brigitte Rack, Udo Jeschke, Ulrich Andergassen, Carolin Bock
Publikováno v:
Translational Oncology
Translational Oncology, Vol 8, Iss 6, Pp 509-516 (2015)
Translational Oncology, Vol 8, Iss 6, Pp 509-516 (2015)
BACKGROUND: We evaluated both estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2) status on disseminated tumor cells (DTCs) in the bone marrow of 54 patients with early breast cancer and compared these with the corresponding pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03d575ccb87b80e80b24d4f9faa5cb00
https://doi.org/10.1016/j.tranon.2015.11.009
https://doi.org/10.1016/j.tranon.2015.11.009
Autor:
Julia Kathrin Jueckstock, Leonie Majunke, Carolin Bock, Charlotte Finkenzeller, Thomas W. P. Friedl, Wolfgang Janni, Julia Neugebauer, Aurelia Pestka, Ulrich Andergassen, Udo Jeschke, Bernadette Jaeger, Brigitte Rack, Sophie F. Doisneau-Sixou
Publikováno v:
Journal of Clinical Oncology. 31:e22059-e22059
e22059 Background: The goal of this study was to evaluate both ER- and HER2-status on DTCs in the bone marrow of patients with early BC and to compare these with the corresponding PT. In case of discordant expression, DTCs might help in properly sele
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2cd4ee8f0623e5031b30ba8e3e66e408
https://doi.org/10.1200/jco.2013.31.15_suppl.e22059
https://doi.org/10.1200/jco.2013.31.15_suppl.e22059
Autor:
Charlotte Finkenzeller, B Jäger, Brigitte Rack, Simone Hofmann, Sophie F. Doisneau-Sixou, Christina Kuhn, Udo Jeschke, Carolin Bock
Publikováno v:
Translational Oncology. 5:475-IN3
Hormone therapy and anti-ErbB2 therapies are prescribed according to the hormone receptor [estrogen receptor α (ERα)/progesterone receptor] and ErbB2 status of the initial tumor, but it appears that circulating tumor cells (CTCs) and, consequently,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b56b1e96d2336df01991354f6b120cb4
https://doi.org/10.1593/tlo.12310
https://doi.org/10.1593/tlo.12310